Infrastructure to consider for your UK Life Sciences Transformational R&D Investment Fund Applications

Designed to accelerate the UK’s position as a global leader in life sciences, the fund supports projects that drive scientific discovery, manufacturing capability, and patient benefit through cutting-edge infrastructure and technology. 

For companies preparing to apply or deliver against this programme, Vanguard Life Sciences offers an essential advantage: rapid, compliant, and scalable facilities that can be deployed in parallel with research and development timelines rather than after them. 

Accelerating readiness for R&D funding projects 

The fund prioritises initiatives that demonstrate clear capacity for innovation and speed to impact. Yet, many organisations face long lead times in creating compliant laboratory and cleanroom environments that meet GMP and ISO 14644 standards. 
Vanguard Life Sciences bridges that gap by delivering modular and mobile facilities that are: 

• Manufactured off-site and installed up to 85% faster than traditional construction 

• Fully compliant with GMP, GxP, and EU Annex 1 standards for regulated environments 

• Scalable and reconfigurable, supporting evolving R&D pipelines and funding milestones 

• Delivered with complete qualification documentation (DQ, IQ, OQ, PQ) and audit readiness 

This approach allows funded projects to move directly from concept to operation, enabling research teams to begin generating data, prototypes, and products while long-term estates plans progress in parallel. 

A trusted partner in regulated infrastructure 

With over two decades of experience through Vanguard Soluții de asistență medicală, our teams have delivered hundreds of compliant modular and mobile environments to the NHS and international partners operating under strict clinical and regulatory oversight. 
Vanguard Life Sciences extends this pedigree to the R&D and manufacturing landscape bringing the same reliability, governance, and validation discipline that healthcare organisations have trusted for years. 

Our cleanroom and laboratory facilities support: 

• Early-stage biotech and start-up innovation 

• Development and Manufacturing for ATMPs, cell and gene therapies, and biologics – tech transfer and scaling as required 

• Analytical and quality control laboratories 

• Containment facilities for biosafety levels up to BSL-3 

• Pilot-scale production and process development 

Enabling collaboration and investment confidence 

The Transformational R&D Investment Fund encourages collaboration between academia, industry, and investors a model Vanguard is built to support. 
Our modular, relocatable, and co-located facilities can house multiple research partners or enable shared innovation clusters, allowing grant recipients to establish project-specific environments without committing to permanent estate development. 

By combining speed, compliance, and flexibility, we help funded organisations demonstrate to investors and government stakeholders that their project infrastructure is ready, robust, and capable of delivering results. 

A foundation for sustainable growth 

Beyond compliance and speed, Vanguard Life Sciences designs for long-term sustainability. Our modular facilities are manufactured to ISO 14001 environmental standards, feature energy-efficient HVAC systems, and can be reconfigured or relocated as programmes evolve  aligning perfectly with the UK’s commitment to responsible, future-ready R&D infrastructure. 

Supporting your next step 

Whether you are preparing a funding proposal, planning infrastructure for a new R&D programme, or scaling up an existing operation, Vanguard Life Sciences provides the expertise, assurance, and delivery capacity to make your vision operational. 

Get in touch with our team to discuss how our compliant modular solutions can strengthen your funding bid or accelerate project delivery under the Life Sciences Transformational R&D Investment Fund.